About
Independent context for evaluating ibogaine evidence, uncertainty, and risk.
Why this resource exists
Prism Aegis is an independent resource on ibogaine addiction research, with attention to study quality, safety, and unanswered questions. It exists to distinguish investigational findings from established treatment evidence.
Gentle Clearing 56 is designed for people seeking careful context: patients, families, clinicians, and policy-minded professionals. The evidence-focused starting point brings that purpose into view without treating uncertainty as a gap to be filled with confidence.
The work is organized for orientation rather than persuasion. Pages identify what a source can support, what it cannot settle, and where a question should remain open. That approach follows the basic premise of evidence-based medicine: decisions should weigh research evidence alongside context and judgment.
Our editorial approach
We use registries, published literature, official materials, and primary-source documentation where available. Study design, sample limits, follow-up, and safety reporting matter as much as a headline result.
What we cover, and how
Our pages group material by the questions readers often need to sort through: evidence quality, comparative context, safety, costs, and treatment claims. The practical guides collected in our scope of support are intended to make the limits of available information easier to see.
We treat registries as useful records of planned and completed studies, not proof of effectiveness. For that reason, references to ClinicalTrials.gov records are considered alongside published methods and results rather than in isolation.
Some adjacent questions need their own boundaries: readers can review discussion of long-term side effects, treatment cost considerations, and claims associated with an ibogaine clinic setting without mistaking those topics for a recommendation.
The principles behind the work
We prioritize plain language and traceable distinctions between what is known, what is suggested, and what is not yet established. This is consistent with the National Academies’ work on reproducibility, which emphasizes methods, transparency, and the limits of any individual result.
- Evidence before hype
- Safety clarity
- Plain language
- Scientific uncertainty
- Independence
Those principles also guide how we frame narrower subjects, including therapy claims for PTSD, discussions of ibogaine and 5-MeO-DMT, and the way a documentary portrayal can differ from a source-based review.
Independent by design
Careful context is not a substitute for care.
Gentle Clearing 56 does not provide medical, legal, or treatment advice. It is not a clinic, medical provider, or licensed treatment center. People considering claims about ibogaine for alcohol addiction should use this resource as context for questions, not as a directive or a replacement for qualified professional assessment.